HelioLiver LDT now available to order through Quest Diagnostics
People crossing a busy city street
News & Media

FiOS1 News: Blood Test Aids Early Cancer Detection

Media Coverage Oct 28, 2018 5 min read FiOS1 News
Share

FiOS1 News reports that the IvyGene blood test — from the Laboratory for Advanced Medicine (now Helio Genomics) — could help detect cancer as early as stage one from a few vials of blood.

Featured on FiOS1 News.

FiOS1 News reported that a new blood test could help detect cancer as early as stage one — and that one Long Island doctor said it could also save lives. The IvyGene test, developed by the Laboratory for Advanced Medicine (now Helio Genomics), requires only a few vials of blood to indicate whether a person may already be developing cancer cells.

Read the Full Article

Source: FiOS1 News. Read the full article.

Related Articles

More from Helio Genomics

NewsMay 12, 2026

Investing: HelioLiver Expands Access Through Quest Diagnostics

Helio broadens access to HelioLiver through Quest Diagnostics’ nationwide network of patient service centers.

Read more
NewsMay 8, 2026

RHT Collaborative on LinkedIn: Helio Joins Microsoft Rural Health

Helio joins the Rural Health Transformation Collaborative, co-chaired by Microsoft, to expand rural early detection.

Read more
VoicesMay 6, 2026

OncoDaily: Bharat Tewarie on a Real Fighting Chance Against Liver Cancer

Helio’s CEO reflects on the landmark CLiMB study and what earlier liver cancer detection means for patients.

Read more